combination therapy

Gebremariam T, Alkhazraji S, Gu Y, Najvar LK, Borroto-Esoda K, Patterson TF, Filler SG, Wiederhold NP, Ibrahim AS. Ibrexafungerp is efficacious in a neutropenic murine[...]

By sjmartinez • April 2, 2024

Rotstein C, Lynch JP 3rd, Zhanel GG. Hospital-acquired bacterial pneumonia (HABP) and ventilator- associated bacterial pneumonia (VABP) in Canada:treatment update and the role of new[...]

By sjmartinez • October 10, 2023

Garon EB, Spira AI, Goldberg SB, Chaft JE, Papadimitrakopoulou V, Cascone T, Antonia SJ, Brahmer JR, Camidge DR, Powderly JD, Wozniak AJ, Felip E, Wu[...]

By sjmartinez • July 24, 2023

Masson R, Seivright J, Shih T, Bennett RG, Hogeling M, Shi VY, Hsiao JL. Trimethoprim/sulfamethoxazole and cephalexin combination therapy in hidradenitis suppurativa patients: A series[...]

By sjmartinez • June 19, 2023

Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in PD-(L)1-Monotherapy Pretreated, Advanced Non-Small Cell Lung Cancer: Results From a Phase 1b Clinical Trial

By sjmartinez • May 7, 2023

Wang X, Liu X, Hugo W, Si L, Shi H. Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments. Front Immunol. 2022[...]

By sjmartinez • November 18, 2022

Nel AE, Mei KC, Liao YP, Liu X. Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with[...]

By sjmartinez • November 15, 2022